These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 33940943)

  • 21. Paired-like homeodomain proteins, Phox2a and Phox2b, are responsible for noradrenergic cell-specific transcription of the dopamine beta-hydroxylase gene.
    Yang C; Kim HS; Seo H; Kim CH; Brunet JF; Kim KS
    J Neurochem; 1998 Nov; 71(5):1813-26. PubMed ID: 9798905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra.
    Bing G; Zhang Y; Watanabe Y; McEwen BS; Stone EA
    Brain Res; 1994 Dec; 668(1-2):261-5. PubMed ID: 7704612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pontine norepinephrine defects in Mecp2-null mice involve deficient expression of dopamine beta-hydroxylase but not a loss of catecholaminergic neurons.
    Zhang X; Su J; Rojas A; Jiang C
    Biochem Biophys Res Commun; 2010 Apr; 394(2):285-90. PubMed ID: 20193660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism.
    Kreiner G; Rafa-Zabłocka K; Barut J; Chmielarz P; Kot M; Bagińska M; Parlato R; Daniel WA; Nalepa I
    Sci Rep; 2019 Mar; 9(1):5262. PubMed ID: 30918302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lesioning noradrenergic neurons of the locus coeruleus in C57Bl/6 mice with unilateral 6-hydroxydopamine injection, to assess molecular, electrophysiological and biochemical changes in noradrenergic signaling.
    Szot P; Knight L; Franklin A; Sikkema C; Foster S; Wilkinson CW; White SS; Raskind MA
    Neuroscience; 2012 Aug; 216():143-57. PubMed ID: 22542679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.
    Hou L; Qu X; Qiu X; Huang R; Zhao X; Wang Q
    J Neuroinflammation; 2020 May; 17(1):148. PubMed ID: 32375810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of reserpine on tyrosine hydroxylase mRNA levels in locus coeruleus and medullary A1 and A2 neurons analyzed by in situ hybridization histochemistry and quantitative image analysis methods.
    Hartman RD; Liaw JJ; He JR; Barraclough CA
    Brain Res Mol Brain Res; 1992 Apr; 13(3):223-9. PubMed ID: 1350653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.
    Nagatsu T; Sawada M
    J Neural Transm Suppl; 2007; (72):113-20. PubMed ID: 17982884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic lesions of the noradrenergic system trigger induction of oxidative stress and inflammation in the ventral midbrain.
    Barut J; Rafa-Zabłocka K; Jurga AM; Bagińska M; Nalepa I; Parlato R; Kreiner G
    Neurochem Int; 2022 May; 155():105302. PubMed ID: 35150790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent changes in noradrenergic locus coeruleus system in wild-type and APP23 transgenic mice.
    Szot P; Van Dam D; White SS; Franklin A; Staufenbiel M; De Deyn PP
    Neurosci Lett; 2009 Sep; 463(1):93-7. PubMed ID: 19631722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer's disease and Parkinson's disease.
    Lin CP; Frigerio I; Bol JGJM; Bouwman MMA; Wesseling AJ; Dahl MJ; Rozemuller AJM; van der Werf YD; Pouwels PJW; van de Berg WDJ; Jonkman LE
    Transl Neurodegener; 2024 Feb; 13(1):9. PubMed ID: 38336865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.
    Ádori C; Glück L; Barde S; Yoshitake T; Kovacs GG; Mulder J; Maglóczky Z; Havas L; Bölcskei K; Mitsios N; Uhlén M; Szolcsányi J; Kehr J; Rönnbäck A; Schwartz T; Rehfeld JF; Harkany T; Palkovits M; Schulz S; Hökfelt T
    Acta Neuropathol; 2015 Apr; 129(4):541-63. PubMed ID: 25676386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locus coeruleus response to single-prolonged stress and early intervention with intranasal neuropeptide Y.
    Sabban EL; Laukova M; Alaluf LG; Olsson E; Serova LI
    J Neurochem; 2015 Dec; 135(5):975-86. PubMed ID: 26333000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noradrenaline is crucial for the substantia nigra dopaminergic cell maintenance.
    Af Bjerkén S; Stenmark Persson R; Barkander A; Karalija N; Pelegrina-Hidalgo N; Gerhardt GA; Virel A; Strömberg I
    Neurochem Int; 2019 Dec; 131():104551. PubMed ID: 31542295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss.
    Iravani MM; Sadeghian M; Rose S; Jenner P
    J Neural Transm (Vienna); 2014 Dec; 121(12):1493-505. PubMed ID: 24781752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notch-Rbpj signaling is required for the development of noradrenergic neurons in the mouse locus coeruleus.
    Shi M; Hu ZL; Zheng MH; Song NN; Huang Y; Zhao G; Han H; Ding YQ
    J Cell Sci; 2012 Sep; 125(Pt 18):4320-32. PubMed ID: 22718343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD.
    Corbillé AG; Coron E; Neunlist M; Derkinderen P; Lebouvier T
    J Parkinsons Dis; 2014; 4(4):571-6. PubMed ID: 25055959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.
    Thomas B; von Coelln R; Mandir AS; Trinkaus DB; Farah MH; Leong Lim K; Calingasan NY; Flint Beal M; Dawson VL; Dawson TM
    Neurobiol Dis; 2007 May; 26(2):312-22. PubMed ID: 17336077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.